General Information of the Compound
Compound ID |
CP0850567
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
Apomorphine hydrochloride
Show/Hide
|
||||||||||||||||||
Synonyms |
(-)-Apomorphinium hydrochloride
(R)-(-)-Apomorphine hydrochloride
314-19-2
6a-beta-Aporphine-10,11-diol, hydrochloride
6abeta-Noraporphine-10,11-diol, 6-methyl-, hyd
9K13MD7A0D
Apomorphin hydrochlorid
Apomorphine HCl
Apomorphine SL
Apomorphine chloride
Apomorphine hydrochloride anhydrous
Apomorphinium chloride
Apomorphinum hydrochloricum
EINECS 206-243-0
N-Methylnorapomorphine hydrochloride
NSC 11442
UNII-9K13MD7A0D
pomorphini hydrochloridum
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C17H18ClNO2
|
||||||||||||||||||
Molecular Weight |
303.789
|
||||||||||||||||||
Canonical SMILES |
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C17H17NO2.ClH/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12;/h2-6,13,19-20H,7-9H2,1H3;1H/t13-;/m1./s1
Show/Hide
|
||||||||||||||||||
InChIKey |
SKYZYDSNJIOXRL-BTQNPOSSSA-N
|
||||||||||||||||||
CAS |
314-19-2
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( Apomorphine SL )
Drug Name | Apomorphine SL |
---|